Zurueck zur Suche

Reporte zur Charge U002539

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

13Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NV 8 CA 3 CO 2

VAERS 2609711

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

mild
Staat
CA
Alter
4,0
Geschlecht
F
Eingang
15.08.2021
Impfdatum
29.07.2021
Beginn
30.07.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Eye swelling Inflammation Injection site discolouration Injection site erythema Injection site induration Rash

Symptomtext

Rash and inflamation of (L) arm that progressed to rash over upper trunk, face and swelling of eyes. By 8/2/21 pt was not having eye swelling, still upper trunk rash and induration with hyperpigmentation and erythema on upper (L) arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site discolouration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Hx of CAH
Vorgeschichte
CAH
Andere Medikamente
Pt. takes Prednisone daily for CAH + Vit. D
Allergien
None
Vorherige Impfungen
-

VAERS 1498348

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

mild
Staat
CA
Alter
4,0
Geschlecht
F
Eingang
23.07.2021
Impfdatum
21.07.2021
Beginn
21.07.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pruritus Urticaria

Symptomtext

Mother reports itching that started on the right arm that gradually emerged as widespread hives, affecting pt's arms, thighs, and back. Mother reported these symptoms 2 days after. Advised benadryl.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1392063

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

mild
Staat
CA
Alter
4,0
Geschlecht
M
Eingang
11.06.2021
Impfdatum
08.06.2021
Beginn
09.06.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Body temperature increased Injection site erythema Injection site swelling Vomiting

Symptomtext

4 year boy with mother. Had vaccine - kinrix to Lt Deltoid area, IM, 0.5mL, on 6/8/21. And MMRV - Rt deltoid same time. Next day (D1) - had temp 100F, and vomited X1. Had Tylenol and was ok. Following day (D2- 6/10) - swelling at local site and redness, mom gave Tylenol, which helped him. Today- D3- area of redness, near 4X5 cm, lt deltoid area, no swelling/no pain/tender. No fever. He continued to use hand with no issues. no issues on Rt arm. He is alert and playful. Rest of systemic exam-N

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
patient was seen on 5/21/21 for mild rash on face, no resp/GI sx, alert and comfy on exam. per parent unsure any thing caused- of note he ate grand ma's crab she prepared fresh on the day, he ate seafoods in past with no issues. managed sx and got better with no issues before decided to give above vaccines after > 3 wks.
Vorgeschichte
resolved mild asthma in past, now no issues. not on any inhalers now.
Andere Medikamente
none.
Allergien
Amoxicillin
Vorherige Impfungen
-

VAERS 2160505

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
CO
Alter
1,0
Geschlecht
M
Eingang
05.03.2022
Impfdatum
03.02.2022
Beginn
03.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event Product label confusion

Symptomtext

No further AE's reported; Employee reported that both PROQUAD and V ARlV AX were administered to a patient; Employee reports that the product labels "look too similar."; This spontaneous report as received who was an executive refers to a 12 months old male patient. The patient's concurrent conditions, concomitant therapies and medical history was not provided. On 03-FEB-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (dose, formulation, route of administration, site of administration, lot # and expiration date were not provided) for prophylaxis. On the same day since the products labels looked too similar (product label confusion), the patient was also vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant Human albumin (PROQUAD) lot # U002539, expiration date not reported, but upon internal validation established as 24-JUL-2022 (dose, formulation, route of administration and site of administration were not provided) for prophylaxis (accidental overdose). No further adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1883930

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
CO
Alter
1,5
Geschlecht
U
Eingang
19.11.2021
Impfdatum
18.10.2021
Beginn
18.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event

Symptomtext

No additional AE reported; the 1.5 year old child wiggled and some of the dose was not administered; This spontaneous report has been received from a medical assistant, referring to an 18-month-old (reported also as "1.5 years old) patient of unknown gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and previous drug reactions and allergies were not provided. On 18-OCT-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), lot number U002539, and expiration date for prophylaxis (dose and frequency were unknown by the reporter; strength, route of administration, anatomical site administration was not provided). During the administration, the child wiggled and some of the dose was not administered (incorrect dose administered). The medical assistant reported that the physician followed up with the child's mother and she reported no adverse events from the administration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1800172

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
NV
Alter
-
Geschlecht
M
Eingang
20.10.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE; PROQUAD vaccine that had undergone temperature excursion; This spontaneous report as received from a registered nurse, referring to a currently 4 years old male patient. Information regarding the patient's pertinent medical history, concurrent condition and drug reactions or allergies was not provided. In 2021 (reported as undergone temperature excursion before calling MNSC), the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (lot # U002539 with expiration date: 24-JUL-2022, dose, strength and route were not reported) for prophylaxis. No additional AE. Administered dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) experienced the temperature excursion under 13.8 degrees Fahrenheit (F) for 1 hour and 48 minutes (product storage error). The previous temperature excursions was not reported. This is one of five reports from the same reporter.; Sender's Comments: US-009507513-2110USA001533: US-009507513-2110USA001521: US-009507513-2110USA001664: US-009507513-2110USA001341:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1775909

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
NV
Alter
-
Geschlecht
M
Eingang
11.10.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

incorrect product storage; No additional AE event reported; This spontaneous report was received from a registered nurse and refers to a currently 4-year-old male patient. Information about medical history, concurrent conditions and concomitant therapies was not provided. On an unknown date, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot number: U002539 with an expiration date: 24-JUL-2022 (exact dose, route and frequency were not reported) for prophylaxis. The vaccine had undergone temperature excursion at 13.8 Degrees Fahrenheit for 1 hour and 48 minutes (product storage error). No previous temperature excursion. No additional adverse event (AE) reported. This is one of 5 reports from the same reporter.; Sender's Comments: US-009507513-2110USA001533: US-009507513-2110USA001521: US-009507513-2110USA001341: US-009507513-2110USA001589:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1775908

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
NV
Alter
-
Geschlecht
M
Eingang
11.10.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

received PROQUAD vaccine that had undergone temperature excursion; No additional AE reported.; This spontaneous report was received from a nurse concerning a male patient of currently 4 years of age. No concurrent condition, medical history, or concomitant therapy was reported. On an unknown date, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (strength and route were unknown; recombinant Human albumin; lot # U002539 has been verified to be a valid lot number, expiration date reported and confirm upon internal validation as 24-JUL-2022) for prophylaxis following a temperature excursion (product storage error). Temperature were 13.8 Fahrenheit (F). The time frame was reported as 1 hour 48 minutes. There was no previous temperature excursion. No adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2110USA001589: US-009507513-2110USA001664: US-009507513-2110USA001341: US-009507513-2110USA001533:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1773354

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
NV
Alter
-
Geschlecht
M
Eingang
09.10.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

She reported that 5 patient's received PROQUAD vaccine that had undergone temperature excursion; No additional AE; This spontaneous report was received from a nurse referring to a currently 4 years old male patient. Information about medical history, concurrent condition and concomitant therapy was not provided. On an unknown date, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (lot # U002539 with an expiration date 24-JUL-2022; strength, dose, route and frequency were not reported) for prophylaxis. The vaccine had undergone temperature excursion at 13.8 Degrees Fahrenheit for 1 hour and 48 minutes (product storage error). No previous temperature excursion. No additional adverse event (AE) reported. The outcome of product storage error was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1669462

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
NV
Alter
-
Geschlecht
U
Eingang
03.09.2021
Impfdatum
13.08.2021
Beginn
13.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's/PQC's; Caller reporting a temperature excursion for frozen products/ Caller notes PROQUAD lots: U006313, T030760, and U002539 have been administered to patients, as well as V ARlV AX lot: U010401.; This spontaneous report was received from an unspecified reporter (also reported on physician's field) (conflicting information) referring to a patient with unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, past drug reactions or allergies. On 11-AUG-2021, the frozen product Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) (lot number U002539, was verified to be a valid lot number with an expiration date reported and established as 24-JUL-2022) experienced a temperature excursion of 7.2 degrees Fahrenheit (F) during a time frame of 56 minutes. On 13-AUG-2021, the patient was vaccinated with this improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) at a dose/frequency reported as one (1) (units not provided) (concentration, exact dose, exact vaccination scheme frequency, route and anatomical site of administration were not reported) for prophylaxis (product storage error). It was stated that no previous temperature excursion was reported. The reporter was unaware if the patient had experienced any symptoms after administration. No additional adverse events (AEs) were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA000271:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1669460

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
NV
Alter
-
Geschlecht
U
Eingang
03.09.2021
Impfdatum
13.08.2021
Beginn
13.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's/PQC's; Caller reporting a temperature excursion for frozen products/ Caller notes PROQUAD lots: U006313, T030760, and U002539 have been administered to patients, as well as V ARlV AX lot: U010401.; This spontaneous report was received from an unspecified reporter (also reported on physician's field) (conflicting information) referring to a patient with unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, past drug reactions or allergies. On 11-AUG-2021, the frozen product Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) (lot number U002539, was verified to be a valid lot number with an expiration date reported and established as 24-JUL-2022) experienced a temperature excursion of 7.2 degrees Fahrenheit (F) during a time frame of 56 minutes. On 13-AUG-2021, the patient was vaccinated with this improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) at a dose/frequency reported as one (1) (units not provided) (concentration, exact dose, exact vaccination scheme frequency, route and anatomical site of administration were not reported) for prophylaxis (product storage error). It was stated that no previous temperature excursion was reported. The reporter was unaware if the patient had experienced any symptoms after administration. No additional adverse events (AEs) were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA000271:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1669459

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
NV
Alter
-
Geschlecht
U
Eingang
03.09.2021
Impfdatum
12.08.2021
Beginn
12.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's/PQC's; Caller reporting a temperature excursion for frozen products/ Caller notes PROQUAD lots: U006313, T030760, and U002539 have been administered to patients, as well as V ARlV AX lot: U010401.; This spontaneous report was received from an unspecified reporter (also reported on physician's field) (conflicting information) referring to a patient with unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, past drug reactions or allergies. On 11-AUG-2021, the frozen product Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) (lot number U002539, was verified to be a valid lot number with an expiration date reported and established as 24-JUL-2022) experienced a temperature excursion of 7.2 degrees Fahrenheit (F) during a time frame of 56 minutes. On 12-AUG-2021, the patient was vaccinated with this improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) at a dose/frequency reported as one (1) (units not provided) (concentration, exact dose, exact vaccination scheme frequency, route and anatomical site of administration were not reported) for prophylaxis (product storage error). It was stated that no previous temperature excursion was reported. The reporter was unaware if the patient had experienced any symptoms after administration. No additional adverse events (AEs) were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA000271:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1669458

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U002539

gering
Staat
NV
Alter
-
Geschlecht
U
Eingang
03.09.2021
Impfdatum
12.08.2021
Beginn
12.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's/PQC's; Caller reporting a temperature excursion for frozen products/ Caller notes PROQUAD lots: U006313, T030760, and U002539 have been administered to patients, as well as V ARlV AX lot: U010401.; This spontaneous report was received from an unspecified reporter (also reported on physician's field) (conflicting information) referring to a patient with unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, past drug reactions or allergies. On 11-AUG-2021, the frozen product Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) (lot number U002539, was verified to be a valid lot number with an expiration date reported and established as 24-JUL-2022) experienced a temperature excursion of 7.2 degrees Fahrenheit (F) during a time frame of 56 minutes. On 12-AUG-2021, the patient was vaccinated with this improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) at a dose/frequency reported as one (1) (units not provided) (concentration, exact dose, exact vaccination scheme frequency, route and anatomical site of administration were not reported) for prophylaxis (product storage error). It was stated that no previous temperature excursion was reported. The reporter was unaware if the patient had experienced any symptoms after administration. No additional adverse events (AEs) were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA000271:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-